Emanuele Soricelli1, Giovanni Casella2, Giovanni Baglio3, Roberta Maselli4, Ilaria Ernesti5, Alfredo Genco2. 1. Department of Surgical Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy. Electronic address: emanuele.soricelli@gmail.com. 2. Department of Surgical Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy. 3. Sapienza University of Rome, Rome, Italy. 4. Endoscopic unit, Division of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy. 5. Department of Experimental Medicine-Medical Physiopathology, Food Science and Endocrinology Section, Sapienza University of Rome, Rome, Italy.
Abstract
BACKGROUND: The postoperative development or worsening of gastroesophageal reflux disease (GERD) represents the major drawback of laparoscopic sleeve gastrectomy (SG). A GERD diagnosis is often based only on symptoms and proton pump inhibitors (PPI) intake, while objective tests like esophagogastroduodenoscopy and pH measurements are performed less frequently. OBJECTIVES: To evaluate the association between reflux symptoms and GERD-related esophageal lesions. SETTINGS: University hospital, Rome, Italy. METHODS: A comprehensive clinical control entailing GERD symptoms, PPI intake, and esophagogastroduodenoscopy was proposed to all patients who underwent SG between June 2007 and February 2011, irrespective of the presence of GERD symptoms. One hundred forty-four of 219 patients agreed to take part in the study (follow-up rate: 65.8%). RESULTS: After a mean follow-up of 66 months, GERD symptoms and PPI intake were recorded in 70.2% and 63.9% of patients, respectively. Mean visual analogue scale score was 2.9 ± 3.3. The overall frequency of erosive esophagitis was 59.8%, while nondysplastic Barrett's esophagus was detected in 13.1%. The frequency of esophageal biliary reflux was 68%. GERD symptoms and visual analogue scale score were not significantly associated with the development of erosive esophagitis and Barrett's esophagus and the severity of the esophageal lesions. Moreover, the frequency of erosive esophagitis and Barrett's esophagus in patients consuming PPI were similar to that of patients without PPI. CONCLUSION: Symptoms investigation alone is not a reliable tool to diagnose GERD after SG. The use of objective diagnostic tests, such as esophagogastroduodenoscopy, should be carefully considered in the postoperative follow-up schedule of SG patients.
BACKGROUND: The postoperative development or worsening of gastroesophageal reflux disease (GERD) represents the major drawback of laparoscopic sleeve gastrectomy (SG). A GERD diagnosis is often based only on symptoms and proton pump inhibitors (PPI) intake, while objective tests like esophagogastroduodenoscopy and pH measurements are performed less frequently. OBJECTIVES: To evaluate the association between reflux symptoms and GERD-related esophageal lesions. SETTINGS: University hospital, Rome, Italy. METHODS: A comprehensive clinical control entailing GERD symptoms, PPI intake, and esophagogastroduodenoscopy was proposed to all patients who underwent SG between June 2007 and February 2011, irrespective of the presence of GERD symptoms. One hundred forty-four of 219 patients agreed to take part in the study (follow-up rate: 65.8%). RESULTS: After a mean follow-up of 66 months, GERD symptoms and PPI intake were recorded in 70.2% and 63.9% of patients, respectively. Mean visual analogue scale score was 2.9 ± 3.3. The overall frequency of erosive esophagitis was 59.8%, while nondysplastic Barrett's esophagus was detected in 13.1%. The frequency of esophageal biliary reflux was 68%. GERD symptoms and visual analogue scale score were not significantly associated with the development of erosive esophagitis and Barrett's esophagus and the severity of the esophageal lesions. Moreover, the frequency of erosive esophagitis and Barrett's esophagus in patients consuming PPI were similar to that of patients without PPI. CONCLUSION: Symptoms investigation alone is not a reliable tool to diagnose GERD after SG. The use of objective diagnostic tests, such as esophagogastroduodenoscopy, should be carefully considered in the postoperative follow-up schedule of SG patients.
Authors: Romano Schneider; Marko Kraljević; Ralph Peterli; Theresa V Rohm; Jennifer M Klasen; Claudia Cavelti-Weder; Tarik Delko Journal: Obes Surg Date: 2020-06-05 Impact factor: 4.129
Authors: Daniel Navarini; Carlos Augusto S Madalosso; Alexandre P Tognon; Fernando Fornari; Fábio R Barão; Richard R Gurski Journal: Obes Surg Date: 2020-04 Impact factor: 4.129
Authors: T Greilsamer; M de Montrichard; S Bruley des Varannes; D Jacobi; M Guillouche; N Regenet; E Mirallié; C Blanchard Journal: Obes Surg Date: 2020-04 Impact factor: 4.129
Authors: Lindel C Dewberry; Jane C Khoury; Shelley Ehrlich; Todd M Jenkins; Andrew J Beamish; Heidi J Kalkwarf; Stavra A Xanthakos; Thomas Inge Journal: J Pediatr Surg Date: 2019-02-28 Impact factor: 2.545
Authors: Reem Matar; Daniel Maselli; Eric Vargas; Jaruvongvanich Veeravich; Fateh Bazerbachi; Azizullah Beran; Andrew C Storm; Todd Kellogg; Barham K Abu Dayyeh Journal: Obes Surg Date: 2020-01 Impact factor: 4.129